We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+8.06%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$66.5B
AUM Growth
+$8.68B
Cap. Flow
+$4.4B
Cap. Flow %
6.62%
Top 10 Hldgs %
43.86%
Holding
2,667
New
353
Increased
1,277
Reduced
719
Closed
180

Sector Composition

Rank Sector Weight
1 Technology 4.02%
2 Financials 2.97%
3 Healthcare 1.72%
4 Consumer Discretionary 1.4%
5 Consumer Staples 1.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNA icon
2301
Ginkgo Bioworks
DNA
$481M
$24.9K ﹤0.01%
+368
New +$33.8K
OTLK icon
2302
Outlook Therapeutics
OTLK
$264M
$24.8K ﹤0.01%
1,150
NU icon
2303
PUT
Nu Holdings
NU
$68.1B
$24.6K ﹤0.01%
+140,300
New +$610K
GALT icon
2304
Galectin Therapeutics
GALT
$229M
$23.8K ﹤0.01%
21,048
CSCO icon
2305
CALL
Cisco
CSCO
$450B
$23K ﹤0.01%
+1,000
New +$45.5K
CRBP icon
2306
Corbus Pharmaceuticals
CRBP
$170M
$22.9K ﹤0.01%
6,901
DERM icon
2307
Journey Medical
DERM
$170M
$22.6K ﹤0.01%
11,764
TLT icon
2308
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$21.8K ﹤0.01%
+7,500
New +$756K
SRXH
2309
SRX Global
SRXH
$35.1M
$21.5K ﹤0.01%
20
GOEV
2310
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$21.3K ﹤0.01%
+38
New +$23.3K
UNH icon
2311
PUT
UnitedHealth
UNH
$382B
$21K ﹤0.01%
5,100
LOGC
2312
DELISTED
ContextLogic
LOGC
$20.7K ﹤0.01%
1,416
-48
-3% -$987
TMDI
2313
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$19.8K ﹤0.01%
29,989
-2,756
-8% -$1.45K
MREO
2314
Mereo BioPharma
MREO
$45.9M
$19.4K ﹤0.01%
25,820
BIAF icon
2315
bioAffinity Technologies
BIAF
$4.15M
$19.4K ﹤0.01%
403
-582
-59% -$44.2K
OCGN icon
2316
Ocugen
OCGN
$410M
$18.7K ﹤0.01%
+14,418
New +$22.5K
HITI
2317
High Tide
HITI
$189M
$18.7K ﹤0.01%
12,169
-133
-1% -$202
EOSE icon
2318
Eos Energy Enterprises
EOSE
$1.23B
$18.6K ﹤0.01%
12,552
+1,447
+13% +$1.88K
OTLY
2319
Oatly Group
OTLY
$417M
$18.1K ﹤0.01%
+519
New +$19.8K
UCO icon
2320
CALL
ProShares Ultra Bloomberg Crude Oil
UCO
$443M
$18K ﹤0.01%
+30,000
New +$904K
BNBX
2321
DELISTED
BNB PLUS CORP
BNBX
$17.4K ﹤0.01%
1
SOND
2322
DELISTED
Sonder
SOND
$16.8K ﹤0.01%
676
SDOT icon
2323
Sadot Group
SDOT
$18.5M
$15.9K ﹤0.01%
9
GMDA
2324
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$15.7K ﹤0.01%
12,138
XPL icon
2325
Solitario Resources
XPL
$68.1M
$15.5K ﹤0.01%
25,010
+10
+0% +$6

Similar funds

Creative Planning's Q4 2022 Portfolio in Review

As of Q4 2022, Creative Planning held 2,667 positions worth $66.5B, up 15% from $57.8B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Creative Planning deployed $4.4B of net new capital in Q4 2022, opening 353 new positions and adding to 1,277 existing holdings. Its largest new stake was Avantis US Equity ETF: 4,140,930 shares worth $282M.

By sector, the portfolio is most concentrated in Technology at 4% of assets, down from 4.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Portfolio S&P 500 ETF, an estimated $76.1M trimmed.

  • Creative Planning's largest Q4 2022 buy was Avantis US Equity ETF: 4,140,930 shares worth $282M.
  • Creative Planning added most to iShares Core MSCI International Developed Markets ETF in Q4 2022, an estimated $322M increase.
  • Creative Planning's biggest Q4 2022 reduction was State Street SPDR Portfolio S&P 500 ETF, cutting an estimated $76.1M.
  • Creative Planning fully exited Veradigm Inc. Common Stock in Q4 2022, selling an estimated $19.6M.
  • Creative Planning's ten largest holdings make up 44% of its $66.5B portfolio in Q4 2022.
  • Creative Planning opened 353 new positions and closed 180 in Q4 2022.
  • Creative Planning's portfolio value rose 15% quarter-over-quarter to $66.5B.

Based on Creative Planning's 13F filing for Q4 2022, filed 10 Feb 2023.